First-Line SpA Treatment — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Two full-dose NSAID trials
BSR 2025/EULAR-ASAS 2022: NSAIDs first-line. At least 2 at full dose 2-4 weeks each. csDMARDs NO efficacy for axial disease. Steroids very limited role. NSAID failure required before biologic.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions